1,033 results on '"Pharmaceutical industry -- International marketing"'
Search Results
2. From Molecule to Market and Beyond: Uniphar Announces Extended Global Commercialization Platform
3. EVERSANA Transforms Pharmacovigilance & Drug Safety Industry with Oracle Collaboration, New Global Patient Support Model
4. Maharashtra pharma all set to expand global footprint
5. SIGA announces U.S. Government procurement order for Oral TPOXX
6. 1nhaler hires pharma industry leaders for key roles ahead of clinical trials
7. United Kingdom : 1nhaler hires pharma industry leaders for key roles ahead of clinical trials
8. Custom Antibody Market to Reach USD 901M by 2029 with 9.2% CAGR | MarketsandMarkets™
9. AstraZeneca is withdrawing its Oxford Covid vaccine worldwide; The jab has been voluntarily withdrawn from the European Union and will be withdrawn throughout the world
10. GET WELL SOON: Beauty brands and suppliers deliver holistic healing via superhero ingredients
11. Nanobiotix inks licensing, co-development & commercialization agreement with Janssen Pharma for potential first-in-class radioenhancer NBTXR3
12. Indoco buys 85% equity stake in US based FPP Holding
13. Amarna Therapeutics announces appointment of Aurelia Caparros as new Chief Business Officer
14. Amarna Therapeutics announces appointment of Aurelia Caparros as new Chief Business Officer
15. Global marketing industry survey to give insights into diversity within the GCC and worldwide
16. ATTORNEY GENERAL REYES ANNOUNCES $350 MILLION SETTLEMENT WITH MULTINATIONAL MARKETING FIRM PUBLICIS OVER ROLE IN OPIOID EPIDEMIC
17. MONTANA TO RECEIVE $1 MILLION FROM OPIOID SETTLEMENT WITH MULTINATIONAL MARKETING FIRM
18. ATTORNEY GENERAL LABRADOR ANNOUNCES $350 MILLION SETTLEMENT WITH MARKETING FIRM OVER ROLE IN OPIOID EPIDEMIC
19. ATTORNEY GENERAL TAYLOR ANNOUNCES SETTLEMENT WITH MULTINATIONAL MARKETING FIRM PUBLICIS FOR ROLE IN OPIOID EPIDEMIC
20. ATTORNEY GENERAL RAOUL REACHES SETTLEMENT WITH MULTINATIONAL MARKETING FIRM FOR ROLE IN OPIOID EPIDEMIC
21. ATTORNEY GENERAL RAOUL ANNOUNCES MULTISTATE AGREEMENT WITH OPIOID MANUFACTURER HIKMA PHARMACEUTICALS
22. ATTORNEY GENERAL JOSH STEIN ANNOUNCES $350 MILLION OPIOID SETTLEMENT WITH MARKETING FIRM PUBLICIS
23. ATTORNEY GENERAL ROSENBLUM ANNOUNCES $350 MILLION NATIONAL SETTLEMENT WITH MARKETING GIANT PUBLICIS OVER ROLE IN OPIOID EPIDEMIC
24. ATTORNEY GENERAL MIYARES ANNOUNCES $350M SETTLEMENT WITH PUBLICIS FOR OPIOID MARKETING
25. AG JENNINGS ANNOUNCES $350 MILLION MULTISTATE SETTLEMENT WITH MARKETING FIRM PUBLICIS OVER ROLE IN OPIOID EPIDEMIC
26. ATTORNEY GENERAL JOSH KAUL ANNOUNCES $350 MILLION SETTLEMENT WITH MARKETING FIRM OVER ITS ROLE IN OPIOID EPIDEMIC
27. ATTORNEY GENERAL TONG ANNOUNCES $350 MILLION SETTLEMENT WITH MULTINATIONAL MARKETING FIRM PUBLICIS OVER ROLE IN OPIOID EPIDEMIC
28. ATTORNEY GENERAL BONTA ANNOUNCES $350 MILLION SETTLEMENT WITH MULTINATIONAL MARKETING FIRM PUBLICIS HEALTH FOR ITS ROLE IN FUELING THE OPIOID CRISIS
29. AG CAMPBELL ANNOUNCES $350 MILLION SETTLEMENT WITH MULTINATIONAL MARKETING FIRM PUBLICIS HEALTH OVER ROLE IN OPIOID EPIDEMIC
30. ATTORNEY GENERAL FORMELLA ANNOUNCES $350 MILLION SETTLEMENT WITH MULTINATIONAL MARKETING FIRM PUBLICIS OVER ROLE IN OPIOID EPIDEMIC
31. ATTORNEY GENERAL CLARK ANNOUNCES VERMONT WILL RECEIVE $1 MILLION IN SETTLEMENT WITH MARKETING FIRM PUBLICIS OVER ROLE IN OPIOID EPIDEMIC
32. ATTORNEY GENERAL PHIL WEISER ANNOUNCES $350 MILLION SETTLEMENT WITH MULTINATIONAL MARKETING FIRM PUBLICIS OVER ROLE IN OPIOID EPIDEMIC
33. Glenmark Life Sciences inks pact with Japanese innovator pharmaceutical company
34. Guardant Health and Hikma Partner to Offer Cancer Screening and Comprehensive Genomic Profiling Tests in the Middle East and North Africa
35. Guardant Health and Hikma partner to offer cancer screening and genomic profiling tests in the ME and N. Africa
36. New History Findings Reported from New York University Shanghai (Marketing Modernity, Selling hazeline: a Comparative Study of Indian and Chinese Markets, 1908-1957)
37. AstraZeneca says Evusheld approved in Japan for COVID-19 prevention, treatment
38. BDA Bolsters Leadership Bench with Appointment of Divisional Vice President of Global Marketing and Creative Services
39. Unicoin Partners with FutureBrand for Iconic Rebranding and Launches a Stunning New Identity
40. Merck Appoints Axel Lober as Head of Global Communications and Stakeholder Engagement
41. NANOBIOTIX Announces Expiration of HSR Waiting Period Regarding the Agreement for Worldwide Co-Development & Commercialization of Potential First-in-Class Radioenhancer NBTXR3
42. PHARMANOVIA APPOINTS NEW GENERAL MANAGER FOR KOREA & JAPAN
43. Propeller
44. FourKites Named a Leader in the 2023 Gartner(R) Magic Quadrant(TM) for Third Consecutive Year
45. Qlik Announces 2023 Global Transformation Awards
46. Court of Justice of the European Union (General Court) Judgment: Pharmaceutical Works Polpharma v EMA (T-611|18)
47. Betagenon AB announces new CEO and new Chairman of the Board
48. Researcher from University of Crete Publishes Findings in Genetics (Transgenic Drosophila to Functionally Validate Fall Armyworm ABCC2 Mutations Conferring Bt Resistance)
49. By 2032, sales of intravenous immunoglobulin are expected to reach US$25,884 million, with 20% of that amount going toward treating immunodeficiency diseases. persistent market analysis
50. UK marketing authorisations for IOPIDINE(R) (apraclonidine) fully transferred to Essential Pharma as change in UK NICE guidelines for glaucoma treatment expected to lead to increase in patients' need for product
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.